about
Risk prediction models for contrast induced nephropathy: systematic reviewX-ray-computed tomography contrast agentsThe Effectiveness of Automatic Recommending System for Premedication in Reducing Recurrent Radiocontrast Media Hypersensitivity ReactionsThe potential utility of iodinated contrast media (ICM) skin testing in patients with ICM hypersensitivity.Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experienceDiagnostic and prognostic utility of non-invasive imaging in diabetes management.Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.Thyroid Dysfunction in Children Exposed to Iodinated Contrast Media.Clinical characteristics of adverse reactions to nonionic low osmolality contrast media in patients transferred from the CT room to the emergency room.Intravascular iodinated contrast media and the anaesthetist.Evaluation of adverse reactions to contrast media in the hospital.Pathophysiology of renal tissue damage by iodinated contrast media.Polymeric nanoparticles for molecular imaging.Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis.Cardiac CT Imaging of Plaque Vulnerability: Hype or Hope?Fixed Drug Eruption due to Iopromide (Ultravist®)Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography.SPIO-RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation.Degradation of Iodinated Contrast Media in Aquatic Environment by Means of UV, UV/TiO2 Process, and by Activated Sludge.Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose.Impact of an electronic consultant system on hypersensitivity reactions to iodinated radiocontrast media: an observational study.The Application of Contrast Media for In Vivo Feature Enhancement in X-Ray Computed Tomography of Soil-Grown Plant Roots.Hypersensitivity reactions to contrast media: prevalence, risk factors and the role of skin tests in diagnosis--a cross-sectional survey.Hybrid BaYbF(5) nanoparticles: novel binary contrast agent for high-resolution in vivo X-ray computed tomography angiography.Development, validation, and application of a novel LC-MS/MS trace analysis method for the simultaneous quantification of seven iodinated X-ray contrast media and three artificial sweeteners in surface, ground, and drinking water.Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization procedures.Contrast Agents and Observing Patient Safety Programs in Radiology Departments in Kermanshah Province Hospitals in West of Iran.
P2860
Q26796473-4321512B-610C-419D-8624-3D7F34870E1FQ28280706-9C7122BE-3776-48C7-983E-2D54B302594CQ28533994-50E8BEC3-518F-4A91-A1BA-8EB07D5FC7E3Q35089302-7867CA52-C7FE-40CB-8046-33728A929FD4Q35594065-6178E630-C055-4FA7-B466-57678895E04CQ35774087-5C73233B-EEAE-4BD4-A553-5480BF94C527Q36513004-C1AABD30-8D17-4BE0-8B17-47DD946C15DEQ36965362-E5755968-E3B4-4123-9B6D-05435B4526B8Q37053273-5C4D08E6-6A6F-4EFA-9474-F074D6C571E4Q37162688-CADF5D93-E795-41A9-97EA-BAC95E21BA86Q37376716-FBC04CC7-78D1-42A6-B710-E3464A5F87BDQ37846792-C7072429-E8A2-481B-A1DA-DAAA4166BF6DQ38195023-C4A9B6F2-002F-455F-B25F-A0FF54CBA439Q38343365-85CA485C-36E3-42A3-A2B7-B786C1473254Q38753197-86C922B9-87B8-4441-9B9C-297C1AA96383Q38794622-E293C3EE-A4B9-4889-99D4-D604240D5597Q39120881-7A074600-0D3C-4B9D-8516-ED03FEA2BDCEQ39216032-99250F7C-2E1A-4293-B89E-473F7180D328Q39371068-E2E0B5D9-03D8-437F-ACEF-E4D6788B63B3Q39521937-B6D371A8-6643-473C-8F06-54E1D95DE012Q40022271-8776BE9B-0DB0-4779-B0D7-1B7576A94222Q40838705-92D93655-C145-4AFD-80BC-3B033884F44DQ41302415-F0AD626B-5B99-4342-8E12-60B4FF3E3FE2Q48101864-B46C0A57-B143-4AF2-BD61-11EFD8D17D5DQ51508890-CCE70DD3-FFA1-4B25-AD35-40626E3B2327Q53131217-E4D36244-BCD2-4656-9F50-82FC987F09B3Q55057736-1036926C-5122-42BE-83F0-803CBDB63E5BQ55235313-E604EFB1-40AB-4613-827D-74BCD371273BQ55267230-32A755C5-1060-42B8-9217-119816D1147D
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
X-ray contrast media--an overview.
@ast
X-ray contrast media--an overview.
@en
X-ray contrast media--an overview.
@nl
type
label
X-ray contrast media--an overview.
@ast
X-ray contrast media--an overview.
@en
X-ray contrast media--an overview.
@nl
prefLabel
X-ray contrast media--an overview.
@ast
X-ray contrast media--an overview.
@en
X-ray contrast media--an overview.
@nl
P1433
P1476
X-ray contrast media--an overview.
@en
P2093
Cathrine Christiansen
P304
P356
10.1016/J.TOX.2004.12.020
P407
P577
2005-04-01T00:00:00Z